| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,080 | $100 | $103.3K |
| J1952 | Leuprolide injectable, camcevi, 1 mg | 760 | $70 | $49.1K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 120 | $200 | $23.9K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 150 | $140 | $21K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 260 | $70 | $18.1K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 110 | $140 | $15.3K |
| 51798 | Providers perform this ultrasound to measure the volume of residual urine in the bladder. | 780 | $10 | $6.2K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 50 | $130 | $5.9K |
| 52281 | The provider uses a cystoscope to view inside the urethra and bladder of a male or female patient. The procedure must include calibrating or dilating a urethral stricture or stenosis. The procedure… | 20 | $280 | $5.9K |
| 51720 | This is a common treatment for bladder cancer. It involves instilling an anticarcinogenic agent into the bladder through a catheter. The provider leaves the agent in the bladder for a period of time… | 70 | $70 | $5.4K |